Gapping up
In reaction to strong earnings/guidance: FRX +7.7%, UL +4.7%, UN +4.6%, DAL +3%, HAL +1.6%, EDU +1.2%, VZ +1.1%, BHI +0.8%, AMTD +0.4%, TRV +0.3%, .
M&A news: BUD +2.8% (Anheuser-Busch InBev announced that an agreement has been entered into whereby AB InBev will reacquire Oriental Brewery from KKR and Affinity for $5.8 billion).
Select metals/mining stocks trading higher: GOLD +5.3% (reports Kibali meets its goals and more), ABX +2.8%, GG +2.1% ( awaits filing of Osisko's Directors' circular), AU +2.1%.
Select oil/gas related names showing strength: SNP +5.5% (China Petroleum (Sinopec) disclosed that Sinopec Group (SHI) increased its shareholding by way of acquiring 173,248,859 A shares on the secondary market as of January 17 2014), SSN +4.6% (provides its weekly operational advisory), SDRL +0.9% (Seadrill unit North Atlantic Drilling offers $600 mln of Unsecured Senior Notes due 2019), RDS.A +0.8% (Royal Dutch Shell announces sale of Wheatstone LNG stake in Australia), TOT +0.7%, SLB +0.7% ( upgraded to Outperform from Neutral at Credit Suisse) .
A few India related names are trading higher: SIFY +3.4%, IBN +2.8%, TTM +2.7%
Other news: YRCW +19.5% (YRC Worldwide and IBT reach tentative agreement on revised proposal), GALT +11.7% (Preclinical Study Demonstrates Effect of Galectin Inhibitor on Serum Biomarker in Fatty Liver Disease With Fibrosis), WPCS +8.3% (updates Bitcoin platform rollout plan; says 'we are formalizing our plans and undertaking several initiatives to launch and begin monetizing this exciting opportunity'), AFFX +6.4% (Affymetrix receives FDA clearance of first-of-its-kind postnatal test for developmental delays and intellectual disabilities in children ), BBRY +6.3% (BlackBerry smartphones will be on 98% of DoD networks, according to reports), PSTI +6.1% (Pluristem Therapeutics' Phase I/II Muscle Injury Trial successfully meets primary safety & efficacy endpoints), PPHM+5.8% (still checking), CYTR +5.8% (Receives FDA Approval to Extend Aldoxorubicin Dosing Cycles until Disease Progression in Upcoming Pivotal, Global Phase 3 Trial for Soft Tissue Sarcomas), IRBT +3.4% (following positive mention on Mad Money), CAMT +3.3% (rebounding from Friday's afternoon decline), NQ +3.1% (Altimeter Capital filed amended 13G), TMUS +3% (Deutsche Telekom has recovered value of TMobile investment, according to reports ), AMD +2.9% (still checking), AZN +2% (still checking), CTIC +2.2% (off premkt highs; still checking for catalyst), CLSN +2% (Initiates Development Program for Glioblastoma Brain Tumors with ThermoDox and HIFU), TS +1.9% (still checking), ASML +1.7% (still checking), NUS +1.1% (Nu Skin confirms its existing sales force will continue to sell products to new and existing customers in China), ACT +0.6% (confirms court upholds Lo Loestrin Fe patent), AMZN +0.6% (e-commerce head to leave the company, according to reports), MA +0.4% (Fed Defends decision to cap swipe fees), IBM +0.4% (speculation that Lenovo may be interested in server unit).
Analyst comments: SRPT +6.4% (upgraded to Buy from Hold at Needham), LUX +6.1% (upgraded to Buy at Deutsche Bank), PLUG +3.4% (Plug Power initiated with an Outperform at Cowen), AA +2.6% (upgraded to Overweight from Neutral at JPMorgan), CCJ +2.5% (upgraded to Buy from Hold at TD Securities), CENX +2.5% (upgraded to Overweight from Underweight at JPMorgan), IQNT+2.3% ( upgraded to Outperform from Mkt Perform at Raymond James), BSX +1.4% (Boston Scientific upgraded to Overweight from Neutral at Piper Jaffray), STX +1.1% (upgraded to Overweight from Equal Weight at Morgan Stanley)
M&A news: BUD +2.8% (Anheuser-Busch InBev announced that an agreement has been entered into whereby AB InBev will reacquire Oriental Brewery from KKR and Affinity for $5.8 billion).
Select metals/mining stocks trading higher: GOLD +5.3% (reports Kibali meets its goals and more), ABX +2.8%, GG +2.1% ( awaits filing of Osisko's Directors' circular), AU +2.1%.
Select oil/gas related names showing strength: SNP +5.5% (China Petroleum (Sinopec) disclosed that Sinopec Group (SHI) increased its shareholding by way of acquiring 173,248,859 A shares on the secondary market as of January 17 2014), SSN +4.6% (provides its weekly operational advisory), SDRL +0.9% (Seadrill unit North Atlantic Drilling offers $600 mln of Unsecured Senior Notes due 2019), RDS.A +0.8% (Royal Dutch Shell announces sale of Wheatstone LNG stake in Australia), TOT +0.7%, SLB +0.7% ( upgraded to Outperform from Neutral at Credit Suisse) .
A few India related names are trading higher: SIFY +3.4%, IBN +2.8%, TTM +2.7%
Other news: YRCW +19.5% (YRC Worldwide and IBT reach tentative agreement on revised proposal), GALT +11.7% (Preclinical Study Demonstrates Effect of Galectin Inhibitor on Serum Biomarker in Fatty Liver Disease With Fibrosis), WPCS +8.3% (updates Bitcoin platform rollout plan; says 'we are formalizing our plans and undertaking several initiatives to launch and begin monetizing this exciting opportunity'), AFFX +6.4% (Affymetrix receives FDA clearance of first-of-its-kind postnatal test for developmental delays and intellectual disabilities in children ), BBRY +6.3% (BlackBerry smartphones will be on 98% of DoD networks, according to reports), PSTI +6.1% (Pluristem Therapeutics' Phase I/II Muscle Injury Trial successfully meets primary safety & efficacy endpoints), PPHM+5.8% (still checking), CYTR +5.8% (Receives FDA Approval to Extend Aldoxorubicin Dosing Cycles until Disease Progression in Upcoming Pivotal, Global Phase 3 Trial for Soft Tissue Sarcomas), IRBT +3.4% (following positive mention on Mad Money), CAMT +3.3% (rebounding from Friday's afternoon decline), NQ +3.1% (Altimeter Capital filed amended 13G), TMUS +3% (Deutsche Telekom has recovered value of TMobile investment, according to reports ), AMD +2.9% (still checking), AZN +2% (still checking), CTIC +2.2% (off premkt highs; still checking for catalyst), CLSN +2% (Initiates Development Program for Glioblastoma Brain Tumors with ThermoDox and HIFU), TS +1.9% (still checking), ASML +1.7% (still checking), NUS +1.1% (Nu Skin confirms its existing sales force will continue to sell products to new and existing customers in China), ACT +0.6% (confirms court upholds Lo Loestrin Fe patent), AMZN +0.6% (e-commerce head to leave the company, according to reports), MA +0.4% (Fed Defends decision to cap swipe fees), IBM +0.4% (speculation that Lenovo may be interested in server unit).
Analyst comments: SRPT +6.4% (upgraded to Buy from Hold at Needham), LUX +6.1% (upgraded to Buy at Deutsche Bank), PLUG +3.4% (Plug Power initiated with an Outperform at Cowen), AA +2.6% (upgraded to Overweight from Neutral at JPMorgan), CCJ +2.5% (upgraded to Buy from Hold at TD Securities), CENX +2.5% (upgraded to Overweight from Underweight at JPMorgan), IQNT+2.3% ( upgraded to Outperform from Mkt Perform at Raymond James), BSX +1.4% (Boston Scientific upgraded to Overweight from Neutral at Piper Jaffray), STX +1.1% (upgraded to Overweight from Equal Weight at Morgan Stanley)